Anika Therapeutics, Inc. (ANIK) Tops Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $21.23 +2.66%
Financial Fact:
Selling, general & administrative: 4.28M
Today's EPS Names:
WPRT, ITRG, ALM, More
Financial Fact:
Selling, general & administrative: 4.28M
Today's EPS Names:
WPRT, ITRG, ALM, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q4 EPS of $0.51, $0.03 better than the analyst estimate of $0.48. Revenue for the quarter came in at $23.3 million versus the consensus estimate of $24.6 million.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
- Erasca, Inc. (ERAS) Misses Q2 EPS by 3c
- Pliant Therapeutics, Inc. (PLRX) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
